Skip to content
Screener

Exelixis EXEL Total Cost of Revenue

Total Cost of Revenue at other companies

Eli Lilly logo
Eli LillyLLY
$3.27B+33.5%
Pfizer logo
PfizerPFE
$4.09B+8.3%
Kura Oncology logo
Kura OncologyKURA
$262K
Opko Health logo
Opko HealthOPK
$83.56M-22.2%
Incyte logo
IncyteINCY
$104.96M+33.3%
CTO
Citius Oncology, Inc.CTOR
$328.88K

Segments

By segment

See full
Reportable Segment$20.66M+6.1%

Other financials

Income statement

See full
Revenue$628.7M+10.6%
Gross profit$608.0M+10.8%
Operating income$248.4M+16.3%
Net income$212.1M+14.7%
EPS (diluted)$0.82+26.2%

Balance sheet

See full
Cash & equivalents$281.4M+71.2%
Total debt$165.9M-7.7%
Total equity$1.8B-9.3%
Total assets$2.5B-6.9%

Cash flow

See full
Operating cash flow$307.7M+528%
CapEx$6.8M+140%
Free cash flow$300.9M+552%

Valuation

See full
Market cap$14.25B+40.4%
Enterprise value$14.14B+39.0%
P/E16.6×-0.3×
P/S5.9×+1.3×

Profitability

See full
Gross margin96.5%-0.1pp
Operating margin39.9%+8.5pp
Net margin35.3%+8.3pp
FCF margin48.1%+14.3pp

Returns & leverage

See full
Return on equity44.4%+15.4pp
Debt / equity0.1×0.0×
Current ratio3.5×-0.1×

Where this comes from

Reported directly by Exelixis in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The source filing: Exelixis’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 4:13 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q3 2026
Accession
0000939767-26-000098
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
Collaboration revenues55,66548,247111,50090,411
Total revenues628,690568,2611,239,5021,123,708
Operating expenses:
Cost of goods sold20,65719,47040,61038,642
Research and development211,987200,356411,903412,589
Selling, general and administrative147,632134,859287,234272,042
Total operating expenses380,276354,685739,747723,273
Income from operations248,414213,576499,755400,435

Item 1. Financial Statements.

FAQ

What is Exelixis's total cost of revenue?
Exelixis (EXEL) reported total cost of revenue of $20.66M in Q2 2026.
How has Exelixis's total cost of revenue changed year-over-year?
Exelixis's total cost of revenue increased by 6.1% year-over-year, from $19.47M to $20.66M.
What is the long-term trend for Exelixis's total cost of revenue?
Over 4 years (2021 to 2025), Exelixis's total cost of revenue has grown at a 12.2% compound annual growth rate (CAGR), from $52.87M to $83.7M.
What does total cost of revenue mean?
The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.

Ask your AI about Exelixis's total cost of revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude